Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

Clinical trial NCT05679024 · RECRUITING

Trial details

NCT number: NCT05679024
Sponsor: Region Stockholm
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Diseases Atrial Fibrillation Stroke Intracerebral Hemorrhage Major Bleed Cardiovascular Complication Death Kidney Transplant; Complications Thromboses, Venous

Start date: 2023-02-17
Primary completion: 2027-12-31
Enrollment: 1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.